MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Cartesian Therapeutics Inc (NASDAQ: RNAC)*
Organization & Developments: Cartesian Therapeutics
Parents
Cartesian Therapeutics Inc (NASDAQ: RNAC)*
Children
*Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer, autoimmune diseases and respiratory diseases.
2020: Cartesian Therapeutics Initiates Clinical Trial of First RNA-Engineered Cell Therapy for Acute Respiratory Distress Syndrome and COVID-19
2021: Dr. Murat Kalayoglu Discusses New Frontline Therapy Treatment for Multiple Myeloma
2024: Cartesian Therapeutics Seems A 'Strong Buy' After Positive Phase 2 Results
2024: Cartesian Therapeutics: Uncertainty Remains
2025: Cartesian Therapeutics: Need To Wait For More Data For Its Novel mRNA Therapies
Jumps
*Key People: Cartesian Therapeutics
Finance & Acquisitions: Cartesian Therapeutics